Shares of Valeant Pharmaceuticals International VRX are lower on the session by 1.12%, trading at $51.31.
Overall call volume is now running at 3.40x the daily average, with 1% of all calls traded being purchases on the offer. 24,303 contracts have traded on the session so far.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in